Home
>
National Drug Code (NDC)
>
Opana
Opana - 63481-816-20 - (oxymorphone hydrochloride)
Drug Information of Opana
| Product NDC: | 63481-816 |
| Proprietary Name: | Opana |
| Non Proprietary Name: | oxymorphone hydrochloride |
| Active Ingredient(s): | 20 mg/1 & nbsp; oxymorphone hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Opana
| Product NDC: | 63481-816 |
| Labeler Name: | Endo Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA201655 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20120320 |
Package Information of Opana
| Package NDC: | 63481-816-20 |
| Package Description: | 2 BLISTER PACK in 1 BOX, UNIT-DOSE (63481-816-20) > 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK |
NDC Information of Opana
| NDC Code | 63481-816-20 |
| Proprietary Name | Opana |
| Package Description | 2 BLISTER PACK in 1 BOX, UNIT-DOSE (63481-816-20) > 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK |
| Product NDC | 63481-816 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | oxymorphone hydrochloride |
| Dosage Form Name | TABLET, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20120320 |
| Marketing Category Name | NDA |
| Labeler Name | Endo Pharmaceuticals Inc. |
| Substance Name | OXYMORPHONE HYDROCHLORIDE |
| Strength Number | 20 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |
